273 related articles for article (PubMed ID: 37736751)
21. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK; Curry CV; Allen CE
Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
[TBL] [Abstract][Full Text] [Related]
22. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
23. Chronic Active Epstein-Barr Virus Infection With Central Nervous System Involvement in Children: A Clinical Study of 22 Cases.
Ou W; Zhao Y; Wei A; Ma H; Zhang L; Lian H; Zhang Q; Chen S; Wang D; Li Z; Wang T; Zhang R
Pediatr Infect Dis J; 2023 Jan; 42(1):20-26. PubMed ID: 36476521
[TBL] [Abstract][Full Text] [Related]
24. Successful Treatment of Relapsed Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis After Allo-HSCT with PD-1 Blockade: A Case Report.
Pi Y; Wang J; Wang Z
Infect Drug Resist; 2022; 15():3751-3756. PubMed ID: 35859915
[TBL] [Abstract][Full Text] [Related]
25. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
27. Acute fibrinous and organizing pneumonia complicated with hemophagocytic lymphohistiocytosis caused by chronic active Epstein-Barr virus infection: a case report.
Wu X; Wang K; Gao Y; Cai Y; Wang W; Zhong D; Zhan Q
BMC Infect Dis; 2021 Dec; 21(1):1207. PubMed ID: 34863102
[TBL] [Abstract][Full Text] [Related]
28. Prognostic scoring system for pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis based on baseline characteristics: A multicenter retrospective study.
Kong Q; Li M; Wang J; Wu L; Zhou D; Yang M; Xu X; Tan Z; Wu X; Wang Z
Pediatr Blood Cancer; 2024 Feb; 71(2):e30772. PubMed ID: 37974392
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
30. L-DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
Br J Haematol; 2020 Nov; 191(3):453-459. PubMed ID: 32525580
[TBL] [Abstract][Full Text] [Related]
31. Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection.
Lee WI; Lin JJ; Hsieh MY; Lin SJ; Jaing TH; Chen SH; Hung IJ; Yang CP; Chen CJ; Huang YC; Li SP; Huang JL
PLoS One; 2013; 8(10):e76711. PubMed ID: 24204658
[TBL] [Abstract][Full Text] [Related]
32. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
Li Y; Li S; Lu N; Wang W; Wang D
Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
[TBL] [Abstract][Full Text] [Related]
33. Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children.
Cheng CN; Chu WY; Chang KC; Chen JS
J Formos Med Assoc; 2022 Nov; 121(11):2351-2355. PubMed ID: 35123848
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders.
Sawada A; Inoue M
Front Pediatr; 2018; 6():334. PubMed ID: 30460216
[TBL] [Abstract][Full Text] [Related]
35. Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.
Sakamoto Y; Mariya Y; Kubo K
Tohoku J Exp Med; 2012 Aug; 227(4):307-11. PubMed ID: 22850617
[TBL] [Abstract][Full Text] [Related]
36. Clinical Significance of Plasma Soluble MICB in Children With EBV-associated Hemophagocytic Lymphohistiocytosis.
Wei A; Zhang L; Ma H; Cui L; Zhang Q; Wang D; Chen S; Du J; Zhao X; Wang T; Zhang R; Zheng H; Li Z
J Pediatr Hematol Oncol; 2023 May; 45(4):e446-e454. PubMed ID: 36898046
[TBL] [Abstract][Full Text] [Related]
37. [Clinical features of adult-onset chronic active Epstein-Barr virus infection].
Kawamoto K; Miyoshi H; Seto M; Kimura H; Ohshima K
Rinsho Ketsueki; 2019; 60(8):944-952. PubMed ID: 31484894
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
[TBL] [Abstract][Full Text] [Related]
39. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
[TBL] [Abstract][Full Text] [Related]
40. PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection.
Song Y; Wang J; Wang Y; Wu L; You Y; Song D; Chen L; Meng G; He X; Cui T; Wang X; Yin Q; Wang Z
Clin Microbiol Infect; 2023 Jun; 29(6):796.e7-796.e13. PubMed ID: 36702399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
